1. |
Zhang J, Wei C, Wang H, et al. Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats. Evid Based Complement Alternat Med 2013; 2013:378298.
|
2. |
Chowdhury D, Tangutur AD, Khatua TN, et al. A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats. J Transl Med 2013; 11:130.
|
3. |
Gul R, Shawl AI, Kim SH, et al. Cooperative interaction between reactive oxygen species and Ca 2+ signals contributes to angiotensin Ⅱ-induced hypertrophy in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2012;302:H901-9.
|
4. |
Drawnel FM, Archer CR, Roderick HL. The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol 2013; 168:296-317.
|
5. |
Tan X, Li J, Wang X, et al. Tanshinone ⅡA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway. Int J Biol Sci 2011; 7:383-9.
|
6. |
Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997; 59:551-71.
|
7. |
Rohini A, Agrawal N, Koyani CN, et al. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 2010; 61:269-80.
|
8. |
Xie ZW. Compilation of the National Chinese Herbal Medicine. Beijing: People’s Health Publishing House; 1996. p. 201.
|
9. |
Cao BJ, Meng QY, Ji N. Analgesic and anti-inflammatory effects of Ranunculus Japonicus extract. Planta Med 1992; 58:496-8.
|
10 |
Yang ZC, Liu Y, Xiao Q, et al. Effect of total Glycosides of Ranunculus Japonicas (TGRJ) on the hemodynamics in anesthetic rats. Pharmacol Clin Chin Mater Med 2011; 27: 81-4.
|
11 |
Rui W, Chen H, Tan Y, et al. rapid analysis of the main components of the total Glycosides of Ranunculus Japonicus by UPLC/Q-TOF-MS. Nat Prod Commun 2010; 5: 783-8.
|
12 |
Dai H, Jia G, Liu X, et al. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca-mediated calcineurin/NFATc3 and CaMKⅡ signaling cascades. Environ Toxicol Pharmacol 2014; 38: 263-71.
|
13 |
Xu XL, Chen XJ, Ji H, et al. Astragaloside Ⅳ improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase. Pharmacology 2008; 81:325-32.
|
14 |
Huang J, Sun W, Huang H, et al. miR-34a modulates angiotensin Ⅱ-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS One 2014; 9:e94382.
|
15 |
Li Y, Shen D, Tang X, et al. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes. Toxicol Lett 2014; 226:257-63.
|
16 |
16.Pan ZW, Zhang Y, Mei DH, et al. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca 2+ -mediated calcineurin and CaMKⅡ signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 2010; 381:137-45.
|
17 |
17.Liu SJ, Zhang X, Yang ZC, et al. Effect of TGRJ on blood press, NO and Ang Ⅱ in renal hypertensive rats. J Chin Med Mater 2012; 35:953-7.
|
18 |
18.Ferrandi M, Barassi P, Tadini-Buoninsegni F, et al. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition. Br J Pharmacol 2013; 169:1849-61.
|
19 |
19.Muller OJ, Lange M, Rattunde H, et al. Transgenic rat hearts overexpressing SERCA2a show improved contra- ctility under baseline conditions and pressure overload. Cardiovasc Res 2003; 59:380-9.
|
20 |
20.Gianni D, Chan J, Gwathmey JK, et al. SERCA2a in heart failure: Role and therapeutic prospects. J Bioenerg Biomembr 2005; 37:375-80.
|